Testing effectiveness (Phase 2)Study completedNCT01926028
What this trial is testing
Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis
Who this might be right for
Vulvovaginal Candidiasis
NovaDigm Therapeutics, Inc. 188